Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Introduction Multiple sclerosis is a chronic inflammatory condition of the central nervous system affecting more than 2 million people worldwide.1 The most common phenotype of MS is the relapsing form (RMS), for which there are approximately 20 currently approved treatments. Within first-line therapy, the oral medications teriflunomide and dimethyl fumarate (DMF), introduced in 2013–2014, have largely replaced platform injectable therapies.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
